Theravance Biopharma Inc Strategic Asset Allocation Index

Latest as of December 2025: 3.8%

Theravance Biopharma Inc strategic asset allocation index. Theravance Biopharma Inc (TBPH) has a Strategic Asset Allocation Index of 3.8% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $11.13 Million) total $11.13 Million, measured against net assets of $296.72 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how tangible is Theravance Biopharma Inc's equity to evaluate the tangible quality of the company's equity base.

SAAI

3.8%
Strategic Assets / Net Assets

Strategic Assets

$11.13 Million
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$296.72 Million
USD

Strategic Asset Allocation Index of Theravance Biopharma Inc (2014–2025)

Strategic asset allocation index of Theravance Biopharma Inc from 2014 to 2025. This chart shows how Theravance Biopharma Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2014 to 2025. As of December 2025, the index stands at 3.8%, representing strategic assets of $11.13 Million against net assets of $296.72 Million USD.

Theravance Biopharma Inc Strategic Asset Allocation Index by Year (2014–2025)

Theravance Biopharma Inc strategic asset allocation index by year from 2014 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Theravance Biopharma Inc from 2014 to 2025, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Theravance Biopharma Inc (TBPH) total market value.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2025 3.8% $11.13 Million $- $11.13 Million $296.72 Million ▲ +3.8 pp
2024 0.0% $0.00 $- $0.00 $175.54 Million ▼ -2.7 pp
2022 2.7% $11.88 Million $11.88 Million $0.00 $441.80 Million ▼ -49.3 pp
2017 52.0% $59.94 Million $10.16 Million $49.78 Million $115.18 Million ▲ +21.2 pp
2016 30.8% $108.03 Million $8.46 Million $99.56 Million $350.23 Million ▲ +5.9 pp
2015 25.0% $60.73 Million $9.87 Million $50.86 Million $243.06 Million ▲ +3.9 pp
2014 21.1% $61.06 Million $9.66 Million $51.40 Million $289.79 Million —
pp = percentage points